Literature DB >> 29175047

Hemorrhagic shock drives glycocalyx, barrier and organ dysfunction early after polytrauma.

Rebecca Halbgebauer1, Christian K Braun2, Stephanie Denk3, Benjamin Mayer4, Paolo Cinelli5, Peter Radermacher6, Guido A Wanner7, Hans-Peter Simmen8, Florian Gebhard9, Daniel Rittirsch10, Markus Huber-Lang11.   

Abstract

Polytrauma (PT) is frequently associated with hemorrhagic shock (HS), which increases morbidity and mortality. Although various aspects of HS have been addressed in PT patients, the impact of an additional HS is largely unknown regarding the development of multiple organ dysfunction associated with disturbed glycocalyx and barrier function early after trauma. A prospective, longitudinal, mono-centered, observational study enrolling severely injured patients (Injury Severity Score, ISS=38.1±2.6) served for an in-depth analysis of blood (drawn on days 0, 1, 2, 3 and 5) and clinical data (up to 21days) of 30 patients who were then stratified into PT with and without HS. HS significantly enhanced signs of acute organ injury, assessed by increased serum concentrations of novel damage markers. Moreover, indicators of glycocalyx and tight-junction dysfunction were found in PT patients all of which were significantly enhanced in co-presence of HS. These markers revealed multiple significant correlations with specific barrier, fluid-balance, coagulation, inflammation, and clinical-outcome parameters. Strikingly, mucosa fragments, which affected clotting, could be detected in serum after PT/HS. The results point to HS as a main driver for glycocalyx and barrier breakdown and suggest novel tools for the monitoring of organ dysfunction in the early course after PT.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glycocalyx; Hemorrhagic shock; Multiple organ failure; Multiple trauma; Systemic inflammatory response syndrome

Mesh:

Substances:

Year:  2017        PMID: 29175047     DOI: 10.1016/j.jcrc.2017.11.025

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  32 in total

1.  A Pilot Study Assessing the Impact of rs174537 on Circulating Polyunsaturated Fatty Acids and the Inflammatory Response in Patients with Traumatic Brain Injury.

Authors:  Charlotte Mae K Waits; Aaron Bower; Kelli N Simms; Bradford C Feldman; Nathan Kim; Susan Sergeant; Floyd H Chilton; Pamela J VandeVord; Carl D Langefeld; Elaheh Rahbar
Journal:  J Neurotrauma       Date:  2020-05-07       Impact factor: 5.269

Review 2.  Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression.

Authors:  Sunil Rangarajan; Jillian R Richter; Robert P Richter; Shyam K Bandari; Kaushlendra Tripathi; Israel Vlodavsky; Ralph D Sanderson
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

Review 3.  Innate immune responses to trauma.

Authors:  Markus Huber-Lang; John D Lambris; Peter A Ward
Journal:  Nat Immunol       Date:  2018-03-05       Impact factor: 25.606

4.  Endogenous Heparin-Like Substances May Cause Coagulopathy in a Patient with Severe Postpartum Hemorrhage.

Authors:  Shichun Wang; Chao Qi; Zhicheng Liu; Ting Xu; Chunyan Yao
Journal:  Transfus Med Hemother       Date:  2019-12-05       Impact factor: 3.747

Review 5.  Immunopathophysiology of trauma-related acute kidney injury.

Authors:  David A C Messerer; Rebecca Halbgebauer; Bo Nilsson; Hermann Pavenstädt; Peter Radermacher; Markus Huber-Lang
Journal:  Nat Rev Nephrol       Date:  2020-09-21       Impact factor: 28.314

6.  Prehospital plasma is associated with distinct biomarker expression following injury.

Authors:  Danielle S Gruen; Joshua B Brown; Francis X Guyette; Yoram Vodovotz; Pär I Johansson; Jakob Stensballe; Derek A Barclay; Jinling Yin; Brian J Daley; Richard S Miller; Brian G Harbrecht; Jeffrey A Claridge; Herb A Phelan; Matthew D Neal; Brian S Zuckerbraun; Timothy R Billiar; Jason L Sperry
Journal:  JCI Insight       Date:  2020-04-23

7.  Elevated Syndecan-1 after Trauma and Risk of Sepsis: A Secondary Analysis of Patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial.

Authors:  Shuyan Wei; Erika Gonzalez Rodriguez; Ronald Chang; John B Holcomb; Lillian S Kao; Charles E Wade
Journal:  J Am Coll Surg       Date:  2018-09-21       Impact factor: 6.113

8.  High Interleukin-6 Plasma Concentration upon Admission Is Predictive of Massive Transfusion in Severely Injured Patients.

Authors:  Nadja Weichselbaum; Daniel Oberladstätter; Christoph J Schlimp; Johannes Zipperle; Wolfgang Voelckel; Oliver Grottke; Georg Zimmermann; Marcin Osuchowski; Herbert Schöchl
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

9.  Fibrinogen Activates PAK1/Cofilin Signaling Pathway to Protect Endothelial Barrier Integrity.

Authors:  Feng Wu; Amanda Chipman; Jing-Fei Dong; Rosemary Ann Kozar
Journal:  Shock       Date:  2021-05-01       Impact factor: 3.454

Review 10.  The future of basic science in orthopaedics and traumatology: Cassandra or Prometheus?

Authors:  Henning Madry; Susanne Grässel; Ulrich Nöth; Borna Relja; Anke Bernstein; Denitsa Docheva; Max Daniel Kauther; Jan Christoph Katthagen; Rainer Bader; Martijn van Griensven; Dieter C Wirtz; Michael J Raschke; Markus Huber-Lang
Journal:  Eur J Med Res       Date:  2021-06-14       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.